Traditionally, the emergence of coronaviruses (CoVs) has been attributed to a gain in receptor 2 binding in a new host. Our previous work with SARS-like viruses argued that bats already 3 harbor CoVs with the ability to infect humans without adaptation. These results suggested that 4 additional barriers limit the emergence of zoonotic CoV. In this work, we describe overcoming 5 host restriction of two MERS-like bat CoVs using exogenous protease treatment. We found that 6 the spike protein of PDF2180-CoV, a MERS-like virus found in a Ugandan bat, could mediate 7 infection of Vero and human cells in the presence of exogenous trypsin. We subsequently show 8 that the bat virus spike can mediate infection of human gut cells, but is unable to infect human 9 lung cells. Using receptor-blocking antibodies, we show that infection with the PDF2180 spike 10 does not require MERS-CoV receptor DPP4 and antibodies developed against the MERS spike 11 receptor-binding domain and S2 portion are ineffective in neutralizing the PDF2180 chimera.
Introduction

27
Since the beginning of the 21 st century, public health infrastructures have been required 28 to periodically respond to new and reemerging zoonotic viral diseases, including influenza, While far from comprehensive, the results indicated that these approaches, reagents, and 48 predictions may prove useful in preparations for future CoV outbreaks.
49
In this study, we extend examination of zoonotic viruses to a novel MERS-like CoV strain 
110
We next examined the capacity of MERS-Uganda spike to infect human respiratory 111 cells, the primary targets of SARS-CoV, MERS-CoV, and other common-cold human CoVs.
112
Using Calu3 cells, a human lung epithelial cell line, we observed robust replication of wild-type 113 MERS-CoV based on RFP expression, consistent with previous studies (17). However, no 114 evidence of infection was noted in MERS-Uganda-infected Calu3 cells in the presence or 115 absence of trypsin. We subsequently explored primary human airway epithelial (HAE) cultures.
116
Grown on an air-liquid interface, HAE cultures have a propensity to facilitate improved 117 infections of several human CoVs and may be more permissive for infection with the PDF-2180 118 spike chimera (20). However, infection with PDF-2180 spike-containing virus showed no 119 evidence of RFP expression, even after several trypsin washes of the apical surface ( Fig. 2C ).
120
Similarly, RNA expression analysis found no evidence for accumulation of viral genomic RNA, 121 indicating no evidence for replication in HAE cultures ( Fig. 2D) . In contrast, wild-type MERS-
122
CoV efficiently infects these HAE cultures, as demonstrated by both RFP expression and viral 123 genomic RNA accumulation. Together, the Calu3 and HAE results suggest that the PDF-2180 124 spike is unable to infect respiratory cells in humans, even in the presence of exogenous trypsin.
125
We next evaluated the capacity of the PDF-2180 chimera to infect cells of the digestive 
226
CoV and SARS-CoV (Fig. 6) . The absence of receptor binding (Fig. 6A) 
233
The requirement for exogenous trypsin treatment is not unique to MERS-Uganda or 
264
Replication in the gut might select for mutations that expand spike processing/tropism and allow 265 replication in other tissues, including the lung, and lead to virulent disease in the new host 266 population, as seen with Porcine Respiratory Coronavirus (41). In examining the threat posed 267 by PDF-2180 and HKU5-CoV, we must consider the emergence of these CoVs in tissues other 268 than the lung and harboring distinct pathologies compared to epidemic SARS and MERS-CoV.
269
The receptor dynamics of MERS-Uganda and HKU5-CoV also remain unclear in the 270 context of this study. In the presence of trypsin, neither spike protein requires the MERS-CoV 271 receptor, DPP4 for entry, which is consistent with the differences between the receptor-binding 272 domains of the bat and epidemic strains. Therefore, it was not surprising that antibodies that 
